Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

0.7020

+0.0854 (13.85%)

At close: Jun 26, 2026, 4:00 PM EDT

0.7400

+0.0380 (5.41%)

After-hours: Jun 26, 2026, 7:59 PM EDT

Vistagen Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Vistagen Therapeutics stock have an average target of $1.00, which predicts a 42.45% increase from the current stock price of 0.7.

Price Target: $1.00 (+42.45%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$1.00	$1.00	$1.00
Change	+42.45%	+42.45%	+42.45%	+42.45%

* Price targets were last updated on Feb 13, 2026.

Analyst Ratings

The average analyst rating for Vistagen Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	5	5	5	5	5	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Myles Minter William Blair	William Blair	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 16, 2026
Paul Matteis Stifel Nicolaus	Stifel Nicolaus	Hold Maintains $1	Hold	Maintains	$1	+42.45%	Feb 13, 2026

Financial Forecast

Revenue This Year

475.00K

from 1.27M

-62.57%

from 1.27M

Revenue Next Year

3.50M

from 475.00K

636.84%

from 475.00K

EPS This Year

-1.48

from -1.83

EPS Next Year

-1.11

from -1.48

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	1.11M	-227.00K	1.06M	486.00K	1.27M	475.00K
Revenue Growth	1.78%	-	-	-54.32%	161.11%	-62.57%
Gross Profit	1.11M	-227.00K	1.06M	486.00K	1.27M	432.25K
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	91.00%
Operating Income	-47.78M	-59.27M	-33.02M	-55.97M	-72.13M	-71.12M
Net Income	-47.76M	-59.25M	-29.36M	-51.42M	-69.69M	-69.55M
EPS	-	-	-	-	-1.83	-1.48
Free Cash Flow	-25.98M	-32.74M	-18.00M	-22.83M	-40.50M	-99.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2027	2028	2029
High	1.9M
Avg	475,000
Low	n/a

Revenue Growth

Revenue Growth	2027	2028	2029
High	49.7%
Avg	-62.6%
Low	-100.0%

EPS Forecast

EPS	2027	2028	2029
High	-1.45
Avg	-1.48
Low	-1.50

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-